Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America
dc.citation.volume | 182 | |
dc.contributor.author | Luque, Marco T. | |
dc.contributor.author | Jenkins, Cathy A. | |
dc.contributor.author | Shepherd, Bryan E. | |
dc.contributor.author | Padgett, Denis | |
dc.contributor.author | Rouzier, Vanessa | |
dc.contributor.author | Succi, Regina Celia M. [UNIFESP] | |
dc.contributor.author | Machado, Daisy M. [UNIFESP] | |
dc.contributor.author | McGowan, Catherine C. | |
dc.contributor.author | Vermund, Sten H. | |
dc.contributor.author | Pinto, Jorge A. | |
dc.coverage | New York | |
dc.date.accessioned | 2020-07-17T14:02:54Z | |
dc.date.available | 2020-07-17T14:02:54Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Objectives To assess the risks of and factors associated with mortality, loss to follow-up, and changing regimens after children with HIV infected perinatally initiate combination antiretroviral therapy (cART) in Latin America and the Caribbean. Study design This 1997-2013 retrospective cohort study included 1174 antiretroviral therapy-naive, perinatally infected children who started cART age when they were younger than 18 years of age (median 4.7 years | en |
dc.description.abstract | IQR 1.7-8.8) at 1 of 6 cohorts from Argentina, Brazil, Haiti, and Honduras, within the Caribbean, Central and South America Network for HIV Epidemiology. Median follow-up was 5.6 years (IQR 2.3-9.3). Study outcomes were all-cause mortality, loss to follow-up, and major changes in cART. We used Cox proportional hazards models stratified by site to examine the association between predictors and times to death or changing regimens. Results Only 52% started cART at younger than 5 years of age | en |
dc.description.abstract | 19% began a protease inhibitor. At cART initiation, median CD4 count was 472 cells/mm3 (IQR 201-902) | en |
dc.description.abstract | median CD4% was 16% (IQR 10-23). Probability of death was high in the first year of cART: 0.06 (95% CI 0.04-0.07). Five years after cART initiation, the cumulative mortality incidence was 0.12 (95% CI 0.10-0.14). Cumulative incidences for loss to follow-up and regimen change after 5 years were 0.16 (95% 0.14-0.18) and 0.30 (95% 0.26-0.34), respectively. Younger children had the greatest risk of mortality, whereas older children had the greatest risk of being lost to follow-up or changing regimens. Conclusions Innovative clinical and community approaches are needed for quality improvement in the pediatric care of HIV in the Americas. | en |
dc.description.affiliation | Social Secur Honduran Inst, Dept Pediat, Tegucigalpa, Honduras | |
dc.description.affiliation | Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA | |
dc.description.affiliation | Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA | |
dc.description.affiliation | Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA | |
dc.description.affiliation | Vanderbilt Inst Global Hlth, Nashville, TN USA | |
dc.description.affiliation | Haitian Grp Studies Kaposi Sarcoma & Opportunist, Port Au Prince, Haiti | |
dc.description.affiliation | Univ Fed Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Fed Minas Gerais, Sch Med, Dept Pediat, Belo Horizonte, MG, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | National Institute of Allergy and Infectious Diseases | |
dc.description.sponsorship | Eunice Kennedy Shriver National Institute of Child Health and Human Development | |
dc.description.sponsorship | National Cancer Institute through Vanderbilt University School of Medicine | |
dc.description.sponsorshipID | National Cancer Institute through Vanderbilt University School of Medicine: U01 AI069923 | |
dc.format.extent | 245-252 | |
dc.identifier | http://dx.doi.org/10.1016/j.jpeds.2016.12.034 | |
dc.identifier.citation | Journal Of Pediatrics. New York, v. 182, p. 245-252, 2017. | |
dc.identifier.doi | 10.1016/j.jpeds.2016.12.034 | |
dc.identifier.issn | 0022-3476 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/55082 | |
dc.identifier.wos | WOS:000396252400040 | |
dc.language.iso | eng | |
dc.publisher | Mosby-Elsevier | |
dc.relation.ispartof | Journal Of Pediatrics | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America | en |
dc.type | info:eu-repo/semantics/article |